Data-Driven Personalized Feedback to Patients with Type 1 Diabetes: A Randomized Trial

Diabetes Technology & Therapeutics
Stein Olav SkrøvsethRagnar M Joakimsen

Abstract

A mobile phone-based application can be useful for patients with type 1 diabetes in managing their disease. This results in large datasets accumulated on the patient's devices, which can be used for individualized feedback. The effect of such feedback is investigated in this article. We developed an application that included a data-driven feedback module known as Diastat for patients on self-measured blood glucose regimens. Using a stepped-wedge design, both groups initially received an application without Diastat. Group 1 activated Diastat after 4 weeks, whereas Group 2 activated Diastat 12 weeks after startup (T1). End points were glycated hemoglobin (HbA1c) level and number of out-of-range (OOR) measurements (i.e., outside the range 72-270 mg/dL). Thirty patients were recruited to the study, and 15 were assigned to each group after the initial meeting. There were no significant differences between groups at T1 in HbA1c or OOR events. Overall, all patients had a decrease of 0.6 percentage points in mean HbA1c (P < 0.001) and 14.5 in median OOR events over 2 weeks (P < 0.001). The study does not provide evidence that data-driven feedback improves glycemic control. The decrease in HbA1c was sizeable and significant, even though...Continue Reading

Associated Clinical Trials

References

Jan 20, 2004·Patient Education and Counseling·Shelley E EllisTom A Elasy
Dec 8, 2009·Endocrine Reviews·Sarah E SiegelaarJ Hans DeVries
Jul 27, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·A Ceriello, M A Ihnat
Mar 12, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·X LiangD Gu
Jul 29, 2011·Translational Behavioral Medicine·William T RileyRobin Mermelstein
Mar 1, 2012·Journal of Telemedicine and Telecare·L S A Nishan SiriwardenaRoshan Hewapathirana
Oct 6, 2012·Diabetes Technology & Therapeutics·Stein Olav SkrøvsethGunnar Hartvigsen
Oct 16, 2012·Journal of Diabetes Science and Technology·Eirik ÅrsandJames T Tufano
Jan 10, 2013·PloS One·Stein Olav SkrøvsethFred Godtliebsen
May 16, 2013·Trials·Stein Olav SkrøvsethRagnar M Joakimsen
Oct 10, 2013·QJM : Monthly Journal of the Association of Physicians·S Goyal, J A Cafazzo
Nov 20, 2013·PloS One·Milena Soriano MarcolinoAntonio Luiz Ribeiro
Jan 1, 2013·JMIR MHealth and UHealth·Naoe TataraGunnar Hartvigsen

❮ Previous
Next ❯

Citations

Mar 5, 2016·Journal of Medical Internet Research·Birthe DinesenThomas Nesbitt
Oct 16, 2015·Current Diabetes Reports·Laura F GarabedianJ Frank Wharam
Jun 9, 2016·BMC Medical Research Methodology·D BarkerM J Campbell
Aug 30, 2016·Canadian Journal of Diabetes·Edmond A RyanRuss Greiner
Nov 9, 2016·Endocrinology and Metabolism Clinics of North America·Andjela DrincicDavid C Klonoff
Feb 7, 2019·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Ericles Andrei BelleiAna Carolina Bertoletti De Marchi
May 29, 2019·Computers, Informatics, Nursing : CIN·Sara AngeliniMarco Di Muzio
Mar 8, 2020·Journal of Clinical Medicine·María Begoña Martos-CabreraJosé L Gómez-Urquiza
Aug 24, 2018·Journal of the American Medical Informatics Association : JAMIA·Sara Belle DonevantSwann Arp Adams
Jan 27, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·John DoupisAlexander Kokkinos
Jun 11, 2020·Sensors·Nichole S Tyler, Peter G Jacobs
May 10, 2018·Journal of General Internal Medicine·Stephanie VeazieMark Helfand
Oct 5, 2018·Current Diabetes Reports·Leslie EilandAndjela Drincic
Mar 6, 2021·Journal of Diabetes Science and Technology·Devin SteenkampBirong Liao
Mar 25, 2021·Journal of Medical Internet Research·Claudia EberleMaxine Löhnert
Jun 18, 2021·Journal of Biomedical Informatics·Omar El-GayarNevine Nawar

❮ Previous
Next ❯

Software Mentioned

Diastat
cSiZer
exactRankTests
R

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.